3 completed, 1 terminated, 1 withdrawn. 5 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 3, Terminated 1, Withdrawn 1 |
| Phase 1 | 2 | Completed 1, Terminated 1 |
Follow John P. Fruehauf: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Taxotere/Prednisone Plus Sunitinib in Chemotherapy-Naïve, Hormone Refractory Prostate Cancer Patients sunitinib malate, docetaxel, prednisone - Prostate Cancer, Adenocarcinoma of the Prostate | Phase 1 / Phase 2 | Terminated | John P. Fruehauf | 4 | 2009-07-01 | 2017-02-01 |
| Neoadjuvant Docetaxel on Newly Diagnosed Intermediate and High Grade Cancer of the Prostate Docetaxel, Prednisone - Prostate Cancer, Adenocarcinoma of the Prostate | Phase 2 | Withdrawn | John P. Fruehauf | 2009-01-01 | 2016-12-08 | |
| Cisplatin Induction With Paclitaxel Consolidation for Stage III-IV Epithelial Ovarian and Primary Peritoneal Cancer Topotecan, Cisplatin, Paclitaxel - Epithelial Ovarian Cancer, Primary Peritoneal Cancer | Phase 2 | Completed | John P. Fruehauf | 40 | 2005-09-01 | 2016-12-08 |
| Docetaxel and Vinorelbine Plus Sargramostim in Metastatic Malignant Melanoma Vinorelbine, Docetaxel, Sargramostim - Metastatic Melanoma | Phase 2 | Completed | John P. Fruehauf | 52 | 2003-04-01 | 2018-05-03 |
| Disulfiram in Patients With Metastatic Melanoma Disulfiram (DSF) - Stage IV Melanoma | Phase 1 / Phase 2 | Completed | John P. Fruehauf | 7 | 2002-01-01 | 2016-12-08 |
Melanoma (2) · Prostatic Neoplasms (2) · Carcinoma, Ovarian Epithelial (1)
Docetaxel (3) · Prednisone (2) · prednylidene (2) · Cisplatin (1) · Disulfiram (1) · Paclitaxel (1) · Sunitinib (1) · Topotecan (1) · Vinorelbine (1) · deltacortene (1) · sargramostim (1)
United States (4)
John P Fruehauf, MD, PhD (2) · John P. Fruehauf, MD, PhD (2) · John Fruehauf, MD (1)